IMI is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.
European Commision Research and Innovation
European Federation of Pharmaceutical Industries
and Associations
SUMMIT receives support from the Innovative Medicines Initiative Joint Undertaking under the grant agreement n° [115006], resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in kind contribution.
Funding Partners
IMI is a public/private partnership between the European Commission (EC) and the European Federation of Pharmaceutical Industries and Associations (EFPIA). Each of the partners contributes with one billion EURO to the IMI budget for research grants. While the budget allocated by the EC will be exclusively awarded to beneficiaries from the public sector and to small and medium sized enterprises (SMEs), EFPIA partners will meet their budgetary obligations through in kind contributions.
For more information, please see the websites of IMI, EFPIA and the European Commission.
